If lab on a chip becomes mainstream for drug testing, and there are already early signs that it will at some stage, it could be huge for Sensera. And I mean $billions huge. We’re basically involved with all significant players in this field currently.
Ann: Sensera expands microfluidic fabrication capabilities, page-4
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
